{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:40:33Z","timestamp":1791520833387,"version":"4.3.4"},"reference-count":36,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,1]]},"DOI":"10.1210\/jc.2010-0225","type":"journal-article","created":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T02:33:47Z","timestamp":1272508427000},"page":"3201-3206","source":"Crossref","is-referenced-by-count":44,"title":["Effect of Atenolol on Aldosterone\/Renin Ratio Calculated by Both Plasma Renin Activity and Direct Renin Concentration in Healthy Male Volunteers"],"prefix":"10.1210","volume":"95","author":[{"given":"Ashraf H.","family":"Ahmed","sequence":"first","affiliation":[{"name":"Endocrine Hypertension Research Centre (A.H.A.-A.A., R.D.G., P.T., E.P., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Endocrine Hypertension Research Centre (A.H.A.-A.A., R.D.G., P.T., E.P., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Taylor","sequence":"additional","affiliation":[{"name":"Endocrine Hypertension Research Centre (A.H.A.-A.A., R.D.G., P.T., E.P., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Ward","sequence":"additional","affiliation":[{"name":"Sullivan and Nicolaides Pathology (G.W.), Brisbane 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Pimenta","sequence":"additional","affiliation":[{"name":"Endocrine Hypertension Research Centre (A.H.A.-A.A., R.D.G., P.T., E.P., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[{"name":"Endocrine Hypertension Research Centre (A.H.A.-A.A., R.D.G., P.T., E.P., M.S.), University of Queensland School of Medicine, Greenslopes and Princess Alexandra Hospitals, Brisbane 4102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113484842200_R1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1521-690X(03)00050-2","article-title":"Primary aldosteronism.","volume":"17","author":"Stowasser","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484842200_R2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/archinte.1969.00300120040006","article-title":"Commentary on incidence of primary aldosteronism: current estimations based on objective data.","volume":"123","author":"Kaplan","year":"1969","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113484842200_R3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension.","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key\n\t\t\t\t2019041113484842200_R4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population.","volume":"14","author":"Lim","year":"2000","journal-title":"J Hum Hypertens"},{"key":"key\n\t\t\t\t2019041113484842200_R5","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484842200_R6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1291\/hypres.30.103","article-title":"Is primary aldosteronism rare or common among hypertensive patients?","volume":"30","author":"Nishikawa","year":"2007","journal-title":"Hypertens Res"},{"key":"key\n\t\t\t\t2019041113484842200_R7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041113484842200_R8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00045415-199907000-00012","article-title":"Primary aldosteronism: a common and curable form of hypertension.","volume":"7","author":"Young Jr","year":"1999","journal-title":"Cardiol Rev"},{"key":"key\n\t\t\t\t2019041113484842200_R9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism.","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113484842200_R10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113484842200_R11","first-page":"457","article-title":"Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis.","volume":"82","author":"Fiad","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484842200_R12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/clpt.1980.221","article-title":"Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney.","volume":"28","author":"Mitnick","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041113484842200_R13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism.","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"key\n\t\t\t\t2019041113484842200_R14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.ten.0000139006.29471.9e","article-title":"The aldosterone-renin ratio in screening for primary aldosteronism.","volume":"14","author":"Stowasser","year":"2004","journal-title":"Endocrinologist"},{"key":"key\n\t\t\t\t2019041113484842200_R15","first-page":"800","article-title":"Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.","volume":"77","author":"Stowasser","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484842200_R16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1210\/jcem-73-5-952","article-title":"Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism.","volume":"73","author":"McKenna","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484842200_R17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","article-title":"Primary aldosteronism.","volume":"18","author":"Gordon","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113484842200_R18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI105464","article-title":"A diurnal rhythm in plasma renin activity in man.","volume":"45","author":"Gordon","year":"1966","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113484842200_R19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome.","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113484842200_R20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00004872-200402000-00006","article-title":"The challenge of more robust and reproducible methodology in screening for primary aldosteronism.","volume":"22","author":"Gordon","year":"2004","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113484842200_R21","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2006.068502","article-title":"Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps.","volume":"52","author":"Schirpenbach","year":"2006","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113484842200_R22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchromb.2007.11.005","article-title":"Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry.","volume":"862","author":"Turpeinen","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key\n\t\t\t\t2019041113484842200_R23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","article-title":"Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry.","volume":"55","author":"Taylor","year":"2009","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113484842200_R24","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline.","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484842200_R25","first-page":"E414","article-title":"Angiotensin II is the mediator of the increase in hepatic angiotensinogen synthesis after bilateral nephrectomy","volume":"265","author":"Hilgenfeldt","year":"1993","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t2019041113484842200_R26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.HYP.25.1.105","article-title":"\u03b2-Adrenergic receptors and angiotensinogen gene expression in mouse hepatoma cells in vitro.","volume":"25","author":"Ming","year":"1995","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113484842200_R27","first-page":"947","article-title":"Effect of aging on renin activity and aldosterone excretion.","volume":"87","author":"Crane","year":"1976","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t2019041113484842200_R28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HJH.0b013e32833266e3","article-title":"Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.","volume":"28","author":"Pizzolo","year":"2010","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113484842200_R29","first-page":"2319","article-title":"Aldosterone: secretion and action","author":"Fuller","year":"2006","journal-title":"In: DeGroot LJ, Jameson JL, eds. Endocrinology. Philadelphia: Elsevier Saunders;"},{"key":"key\n\t\t\t\t2019041113484842200_R30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJM197212142872401","article-title":"Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.","volume":"287","author":"Bu\u0308hler","year":"1972","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113484842200_R31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.0954-6820.1975.tb19560.x","article-title":"Effect of alprenolol and hydralazine on plasma renin concentration in patients with arterial hypertension.","volume":"198","author":"Pedersen","year":"1975","journal-title":"Acta Med Scand"},{"key":"key\n\t\t\t\t2019041113484842200_R32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/BF01468983","article-title":"[Effect of chronic \u03b2-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author\u2019s transl)]","volume":"53","author":"Stumpe","year":"1975","journal-title":"Klin Wochenschr"},{"key":"key\n\t\t\t\t2019041113484842200_R33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1507\/endocrj.K08E-370","article-title":"Adrenal Cushing\u2019s syndrome due to bilateral macronodular adrenal hyperplasia: prediction of the efficacy of \u03b2-blockade therapy and interest of unilateral adrenalectomy.","volume":"56","author":"Mazzuco","year":"2009","journal-title":"Endocr J"},{"key":"key\n\t\t\t\t2019041113484842200_R34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00045391-199905000-00004","article-title":"Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.","volume":"6","author":"Pesant","year":"1999","journal-title":"Am J Ther"},{"key":"key\n\t\t\t\t2019041113484842200_R35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/jcem-34-5-819","article-title":"Plasma aldosterone and renin activity during the menstrual cycle.","volume":"34","author":"Katz","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113484842200_R36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1681\/ASN.V132446","article-title":"Variation in the renin angiotensin system throughout the normal menstrual cycle.","volume":"13","author":"Chidambaram","year":"2002","journal-title":"J Am Soc Nephrol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/7\/3201\/9067087\/jcem3201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T21:14:09Z","timestamp":1635282849000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/7\/3201\/2596261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-0225","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,1]]}}}